after an initial 1 week phase during which all patients received protamine bound insulin twice daily , the patients either continued on nph insulin ( group a , n = 11 ) or were randomly switched to human proinsulin ( group b , n = 12 ) .
C0021641
insulin
C0033362
proinsulin